Entity
  • FRANCE REIN

    Created in 1972


  • Up & running (A)
    Existing signals show a regular activity
  • Social networks

    2,822
  • Activities

  • Entity types

  • Location

    19 Bd Malesherbes, 75008 Paris, France

    Paris

    France

  • Employees

    Scale: 2-10

    Estimated: 16

  • Engaged catalyst

    15
    0 0
  • Added in Motherbase

    1 year, 2 months ago
Description
  • Value proposition

    [Automatic translation follows] Solidarity network in action

    For almost 50 years, France Rein has been acting at the service of the millions of French people concerned by a chronic kidney disease.

    Recognized of public utility and approved by the Ministry of Health, our independent patient association is committed to these diseases everywhere and at all stages.

    Our association of patients, with 11,000 members and led by more than 600 volunteers throughout France, has the objectives:

    PREVENT
    The evolution of kidney disease, by informing, detecting and encouraging medical research in order to reduce the number of people entering supplementary treatment each year.

    INFLUENCE
    Public authorities in the definition of health policies. Recognize kidney disease recognized as a major public health issue.

    IMPROVE
    The quality of life and treatment of patients by helping them build their life project with the disease, support their loved ones.

    Representation of users, help with patients and relatives, information and awareness -raising, and prevention of kidney diseases

  • Original language

    Réseau solidaire en action

    Depuis près de 50 ans, France Rein agit au service des millions de Français concernés par une maladie rénale chronique.

    Reconnue d’Utilité Publique et agrée par le Ministère de la Santé, notre association de patients indépendante s’engage contre ces maladies partout et à tous les stades.

    Notre association de patients, comptant 11 000 membres et animée par plus de 600 bénévoles dans toute la France, a pour objectifs :

    PRÉVENIR
    l’évolution de la maladie rénale, en informant, en dépistant et en encourageant la recherche médicale afin de réduire le nombre de personnes entrant chaque année en traitement de suppléance.

    INFLUENCER
    les pouvoirs publics dans la définition des politiques de santé. Faire reconnaître la maladie rénale comme un enjeu de santé publique majeur.

    AMÉLIORER
    la qualité de vie et de traitement des patients en les aidant à construire leur projet de vie avec la maladie, soutenir leurs proches.

    Représentation des Usagers, Aide aux malades et proches, Information et sensibilisation, and Prévention des maladies rénales

Catalyst interactions
Catalyst TypeTweets Articles
AstraZeneca
AstraZeneca
Pharmaceutical, Pharmaceutical Manufacturing
AstraZeneca
Pharmaceutical, Pharmaceutical Manufacturing
Other

16 Mar 2025


GSK
GSK
Pharmaceutical, Pharmaceutical Manufacturing
GSK
Pharmaceutical, Pharmaceutical Manufacturing
Other

10 Jan 2025


Novartis
Novartis
Pharmaceutical, Pharmaceutical Manufacturing
Novartis
Pharmaceutical, Pharmaceutical Manufacturing
Other

11 Feb 2024


Fresenius Medical Care
Fresenius Medical Care
Pharmaceutical, Hospitals and Health Care
Fresenius Medical Care
Pharmaceutical, Hospitals and Health Care
Other

12 Mar 2024


Ramsay Santé
Ramsay Santé
Health, Hospitals and Health Care
Ramsay Santé
Health, Hospitals and Health Care
Other

14 May 2024


Social network dynamics
Loading...